Web Results

www.purdue.edu/.../Q4/targeted-therapies-developed-to-reduce-lung-fibrosis.html

Idiopathic pulmonary fibrosis (IPF) is a lethal disease with an average life expectancy of 3 to 5 years. IPF is characterized by progressive stiffening of the lung parenchyma due to excessive deposition of collagen, leading to gradual failure of gas exchange.

medicalxpress.com/news/2019-09-treatment-pulmonary-fibrosis.html

A new target for the treatment of idiopathic pulmonary fibrosis More information: B. Ng el al., "Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis," Science Translational ...

en.wikipedia.org/wiki/Idiopathic_pulmonary_fibrosis

Idiopathic pulmonary fibrosis (IPF) is a type of chronic scarring lung disease characterized by a progressive and irreversible decline in lung function. The tissue in the lungs becomes thick and stiff, which affects the tissue that surrounds the air sacs in the lungs. Symptoms typically include gradual onset of shortness of breath and a dry cough. Other changes may include feeling tired, and ...

globalresearchsyndicate.com/2020/12/05/idiopathic-pulmonary-fibrosis-treatment...

DataIntelo has published a market research report on the Idiopathic Pulmonary Fibrosis Treatment market considering the changes in the market

www.medicalnewstoday.com/articles/idiopathic-pulmonary-fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung condition. IPF causes scar tissue to build up in the lungs, leading to shortness of breath and a persistent cough.

www.pubfacts.com/detail/33276250/Statins-cause-of-fibrosis-or-the-opposite...

Background And Objective: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible interstitial lung disease with poor prognosis despite the recent availability of two antifibrotic drugs.Patients are more susceptible to cardiovascular comorbidities. In this study, we aimed to determine the impact of concomitant cardiovascular drugs on disease progression and survival in a modern ...

www.news-medical.net/news/20190629/New-target-identified-for-treatment-of...

IPF is a type of lung disease that results in fibrosis, or scarring, of the lungs. As the disease progresses and the scarring worsens, patients are unable to take a deep breath and the lungs can ...

emedicine.medscape.com/article/301226-guidelines

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause, primarily occurring in older adults, limited to the lungs, and associated with the histopathologic and/or radiologic pattern of usual interstitial pneumonia (UIP). Of the seven listed idiopathic inters...

www.ofevhcp.com

OFEV is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). OFEV is indicated for the treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype. OFEV is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

www.epainassist.com/chest-pain/lungs/dealing-with-exacerbations-of-idiopathic...

The main symptom of Idiopathic pulmonary fibrosis is shortness of breath, which causes reduced oxygen in the blood, leading to fatigue. (5) The exact cause of idiopathic pulmonary fibrosis remains unknown, though some cases of the disease have been found to result from infections, environmental exposures, certain medications, and other diseases.